Methods are provided for treating autism spectrum disorders (ASD) using agents that activate the locus coeruleus-noradrenergic (LC-NA) system of the brain and for screening for compounds for treating ASD comprising determining whether or not the compounds activate the LC-NA system.
Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system